64013-70-3 Usage
Uses
Used in Pharmaceutical Industry:
Kanamycin Acid Sulfate is used as an antibiotic for treating various bacterial infections. Its application is primarily due to its ability to inhibit bacterial growth by interfering with the synthesis of bacterial cell walls, thus providing a therapeutic solution for combating infections caused by susceptible bacteria.
Used in Veterinary Medicine:
In the veterinary field, Kanamycin Acid Sulfate is used as an antibacterial agent for treating bacterial infections in animals. Its application is based on its effectiveness in targeting and eliminating harmful bacteria, thereby promoting the health and well-being of animals.
Used in Agricultural Industry:
Kanamycin Acid Sulfate is also utilized in the agricultural sector, particularly for the protection of crops against bacterial diseases. Its application in this industry is due to its ability to control and prevent the spread of bacterial pathogens that can cause significant damage to crops, ensuring a healthy and productive agricultural yield.
Check Digit Verification of cas no
The CAS Registry Mumber 64013-70-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,0,1 and 3 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 64013-70:
(7*6)+(6*4)+(5*0)+(4*1)+(3*3)+(2*7)+(1*0)=93
93 % 10 = 3
So 64013-70-3 is a valid CAS Registry Number.
64013-70-3Relevant articles and documents
The last step of kanamycin biosynthesis: Unique deamination reaction catalyzed by the α-ketoglutarate-dependent nonheme iron dioxygenase KanJ and the NADPH-dependent reductase KanK
Sucipto, Hilda,Kudo, Fumitaka,Eguchi, Tadashi
supporting information; experimental part, p. 3428 - 3431 (2012/06/30)
Mystery solved: Using heterologous expression, the activities of two enzymes exclusively belonging to the kanamycin biosynthetic pathway have been identified in vitro. A distinctive reaction mechanism (see scheme) to produce kanamycin is proposed and the previously unknown catalytic deamination activity of KanJ dioxygenase is uncovered. Copyright
Method for apparatus for a defined serumfree medical solution useful for corneal preservation
-
, (2008/06/13)
A defined serumfree medical solution for applications in Ophthalmology, that contains one or more cell nutrient supplements which maintains and enhances the preservation of eye tissues, including human corneal tissues at low temperatures (2° C. to 15° C.). This solution is composed of a defined aqueous nutrient and electrolyte solution, supplemented with a glycosaminoglycan(s), a deturgescent agent(s), an energy source(s), a buffer system(s), an antioxidant(s), membrane stabilizing components, antibiotic(s), ATP precursors and nutrient cell supplements.
